Clinical trial
The Beijing Angle Closure Progression Study (BAPS)
NCT05563623 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Beijing Angle Closure Progression Study (BAPS)
- Lead sponsor
- Peking University People's Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 4, 2022
- Completion date
- December 31, 2030
- Enrollment
- 825 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
angle-closure glaucoma